Can you survive Leptomeningeal cancer?
Since leptomeningeal disease cancer cells float in the cerebrospinal fluid, they can quickly spread throughout the central nervous system. As a result, leptomeningeal disease has a poor prognosis, with survival typically measured in months.
Can you survive leptomeningeal metastases?
Leptomeningeal metastases from solid tumors confer a poor overall prognosis. Mean survival from the time of diagnosis is 2 to 4 months. However, subsets of patients, specifically those with lymphoma and breast cancer, may survive for more than 1 year with a reasonably good quality of life.
Has Leptomeningeal Carcinomatosis survived?
All cases had a progression-free survival of at least 6 months, with some well over 24 months, which is longer than the documented average LC from breast cancer. Most of these patients also received prior systemic chemotherapy for systemic disease control.
Is Leptomeningeal disease rare?
Leptomeningeal disease is an uncommon condition that occurs in about 5% of cancer patients.
What does Leptomeningeal look like on MRI?
On MRI, leptomeningeal enhancement is characterized by high signal intensity within the subarachnoid space of the sulci and cisterns on post-contrast T1 weighted images.
How do you know if you have leptomeningeal disease?
The most common problems are headaches, nausea, vomiting, double vision, weakness, loss of urine control, and difficulty walking, but leptomeningeal disease can cause almost any neurological problem, depending on where the cancer cells land.
Can Leptomeningeal be misdiagnosed?
We experienced a case of leptomeningeal carcinomatosis (LC) from gastric cancer that was originally misdiagnosed as vestibular schwannoma based on the similar radiological characteristics. To our knowledge, LC from gastric cancer is very rare.
What is the progression of leptomeningeal disease?
With progression of leptomeningeal metastases, new signs and symptoms appear and pre-existing findings worsen. Patients with underlying solid tu- mors are more likely to present with spinal or radic- ular symptoms, whereas patients with hematologic malignancies more often present with cranial nerve dysfunction.
